TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Castle Biosciences Inc.
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

Castle Biosciences announced its Q3 2025 financial results and launched AdvanceAD-Tx, a genetic expression test to help guide systemic treatment decisions for patients with moderate-to-severe atopic dermatitis aged 12 and older.

Insights
BCS   neutral

Mentioned as one of the sales agents and forward purchasers, playing a standard financial intermediary role


CSTL   positive

Company is expanding its diagnostic test portfolio with a new targeted solution for atopic dermatitis treatment, demonstrating ongoing innovation and market expansion